Voyager Therapeutics Inc. (NASDAQ:VYGR) went up by 17.74% from its latest closing price compared to the recent 1-year high of $10.60. The company’s stock price has collected 18.46% of gains in the last five trading sessions.
Is It Worth Investing in Voyager Therapeutics Inc. (NASDAQ :VYGR) Right Now?
Plus, the 36-month beta value for VYGR is at 1.17. Opinions of the stock are interesting as 2 analysts out of 7 who provided ratings for Voyager Therapeutics Inc. declared the stock was a “buy,” while 1 rated the stock as “overweight,” 4 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $6.75, which is $0.76 above the current price. VYGR currently public float of 32.94M and currently shorts hold a 3.80% ratio of that float. Today, the average trading volume of VYGR was 601.65K shares.
VYGR’s Market Performance
VYGR stocks went up by 18.46% for the week, with a monthly drop of -4.73% and a quarterly performance of -35.61%, while its annual performance rate touched 33.33%. The volatility ratio for the week stands at 9.12% while the volatility levels for the past 30 days are set at 7.97% for Voyager Therapeutics Inc. The simple moving average for the period of the last 20 days is 5.22% for VYGR stocks with a simple moving average of 25.10% for the last 200 days.
Analysts’ Opinion of VYGR
Many brokerage firms have already submitted their reports for VYGR stocks, with Robert W. Baird repeating the rating for VYGR by listing it as a “Outperform.” The predicted price for VYGR in the upcoming period, according to Robert W. Baird is $9 based on the research report published on October 07th of the previous year 2021.
Robert W. Baird, on the other hand, stated in their research note that they expect to see VYGR reach a price target of $6, previously predicting the price at $18. The rating they have provided for VYGR stocks is “Neutral” according to the report published on February 26th, 2021.
Wedbush gave a rating of “Neutral” to VYGR, setting the target price at $6 in the report published on February 03rd of the previous year.
VYGR Trading at -11.90% from the 50-Day Moving Average
After a stumble in the market that brought VYGR to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -44.91% of loss for the given period.
Volatility was left at 7.97%, however, over the last 30 days, the volatility rate increased by 9.12%, as shares sank -3.47% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -29.04% lower at present.
During the last 5 trading sessions, VYGR rose by +18.46%, which changed the moving average for the period of 200-days by +74.33% in comparison to the 20-day moving average, which settled at $5.54. In addition, Voyager Therapeutics Inc. saw 115.50% in overturn over a single year, with a tendency to cut further gains.
Reports are indicating that there were more than several insider trading activities at VYGR starting from EcoR1 Capital, LLC, who purchase 376,000 shares at the price of $5.66 back on Jun 23. After this action, EcoR1 Capital, LLC now owns 4,753,907 shares of Voyager Therapeutics Inc., valued at $2,126,543 using the latest closing price.
EcoR1 Capital, LLC, the 10% Owner of Voyager Therapeutics Inc., purchase 101,400 shares at $5.28 during a trade that took place back on Jun 21, which means that EcoR1 Capital, LLC is holding 4,377,907 shares at $535,504 based on the most recent closing price.
Stock Fundamentals for VYGR
Equity return is now at value -76.80, with -34.90 for asset returns.